Jasper Therapeutics, Inc., (JSPR): Price and Financial Metrics
JSPR Price/Volume Stats
| Current price | $4.74 | 52-week high | $26.83 |
| Prev. close | $4.52 | 52-week low | $3.13 |
| Day low | $4.56 | Volume | 158,700 |
| Day high | $4.99 | Avg. volume | 429,107 |
| 50-day MA | $4.76 | Dividend yield | N/A |
| 200-day MA | $13.88 | Market Cap | 71.20M |
JSPR Stock Price Chart Interactive Chart >
Jasper Therapeutics, Inc., (JSPR) Company Bio
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191, a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
JSPR Price Returns
| 1-mo | 13.94% |
| 3-mo | -13.66% |
| 6-mo | -78.55% |
| 1-year | -77.17% |
| 3-year | -84.15% |
| 5-year | N/A |
| YTD | -77.83% |
| 2024 | 170.98% |
| 2023 | 63.39% |
| 2022 | -93.85% |
| 2021 | -21.58% |
| 2020 | N/A |
Loading social stream, please wait...